id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-347982-omxcdiwt	Basso, Fernanda Gisele	Cooperative efforts on developing vaccines and therapies for COVID-19 Cooperative efforts for COVID-19	2020-09-06		.txt	text/plain	3433	168	36	The present research analyzes how the cooperation networks were set off considering the clinical trials on therapies and vaccines that were developed specifically to treat or prevent COVID-19. For the construction of cooperation networks, it was assumed that organizations signed agreements and/or treaties to develop specific studies, establishing joint ownership of the results and the new drug or vaccine, with the purpose of forming an alliance for innovation [20] . Regarding the distribution of the types of organizations that cooperate by category (Fig 3) , a greater diversity of partnerships was observed in antibodies, followed by vaccines and proteins, because these categories address complex therapies and require complementarity among several disciplines (e.g., adjuvants in Because clinical adoption and commercial success are due to the incorporation degree of existing practices in innovation processes [23] , the diffusion of disruptive technologies in this field may encounter greater challenges.	./cache/cord-347982-omxcdiwt.txt	./txt/cord-347982-omxcdiwt.txt